TimesLeader.com

Philly’s Hanson suspended

The Eagles corner will miss four games after testing positive for a diuretic.

The Associated Press

PHILADELPHIA — Philadelphia Eagles cornerback Joselio Hanson was suspended four games by the NFL on Wednesday for violating the league’s drug policy.

Hanson’s attorney, David Cornwell, said in a statement that Hanson did not use steroids but tested positive for a diuretic after last year’s NFC title game against Arizona.

“Joselio did not use steroids or any other substance that would enhance his performance,” Cornwell said.

While not specifying what product was used, Cornwell said Hanson “felt ‘bloated’ after eating Chinese food and took a pill that turned out to be a diuretic.”

Cornwell said the NFL’s policy on diuretics is misguided because it assumes they are used to mask the use of performance-enhancing drugs.

He said he had hoped the league would delay making a decision on Hanson until there was a resolution in another case involving four players who have suspensions pending for taking a banned diuretic.

Two Minnesota Vikings, Kevin Williams and Pat Williams — who are not related — tested positive in 2008 for the diuretic bumetanide, which is banned by the NFL because of its masking capabilities. The players acknowledged taking the over-the-counter weight loss supplement StarCaps, which did not state on the label that it contained bumetanide. Neither player is accused of taking steroids.

The NFL issued four-game suspensions, but both players sued the NFL in state court, arguing the league’s testing violated Minnesota laws. The case was moved to federal court, and the NFL players union filed a similar lawsuit on behalf of the Williamses and two New Orleans Saints players also suspended.

In May, a federal judge dismissed the union’s lawsuit and several claims in the Williamses’ case but sent two claims involving Minnesota workplace laws back to state court. A judge there issued an injunction prohibiting the NFL from suspending the players and has scheduled the trial for March.

That led the NFL to allow New Orleans defensive ends Charles Grant and Will Smith, who had also been issued four-game suspensions for testing positive for bumetanide, to continue playing.

“We also argued that the accommodation allowing the ’StarCaps players’ to continue playing supported allowing Joselio to continue playing as well,” Cornwell said in his statement. “Our appeal to fairness was rejected.”

“As Mr. Cornwell knows, the details of the appeals process are confidential,” NFL spokesman Greg Aiello said in a statement. “Nevertheless, his statement contains multiple inaccuracies and misleading assertions. Our program of testing and discipline for violations remains in place.”